An Update of Acyl-CoA: Cholesterol Acyltransferase Inhibition in Animal and Human In Vitro and In Vivo Models of Atherosclerosis

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 1, Iss. 2, 2001-08 ,pp. : 141-150

Bentham Science Publishers

Access to resources Recommend Favorite

Human Liver-Specific Very-Long-Chain Acyl-Coenzyme A Synthetase: cDNA Cloning and Characterization of a Second Enzymatically Active Protein

By Steinberg S.J.   Wang S.J.   McGuinness M.C.   Watkins P.A.  

Molecular Genetics and Metabolism, Vol. 68, Iss. 1, 1999-09 ,pp. : 32-42

Academic Press

Access to resources Recommend Favorite

Lecithin cholesterol acyltransferase activity following orthotopic liver transplantation

By Mears D.   Chui A.K.K.   Stewart P.   Burns J.   Sullivan D.   Bowen D.   Sheil A.G.R.  

Transplantation Proceedings, Vol. 32, Iss. 1, 2000-02 ,pp. : 169-170

Elsevier

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 441-453

Bentham Science Publishers

Access to resources Recommend Favorite

The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists,PPAR&ggr; Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 35-52

Bentham Science Publishers

Access to resources Recommend Favorite